Abstract
Infective endocarditis in neonates can be fatal. Adjunctive rifampin therapy might be effective as salvage therapy in critically ill patients with
Staphylococcus aureus
native valve endocarditis (NVE). We present a case of a full‐term neonate with NVE who had a favorable clinical outcome after adding rifampin to standard therapy.
Adding rifampin in a critically ill neonate with native valve
Staphylococcus aureus
endocarditis might be effective and lifesaving. Further studies are needed to determine rifampin's effect on neonatal
Staphylococcus aureus
native valve endocarditis.